4//SEC Filing
Shahidi Javad 4
Accession 0000899243-22-013424
CIK 0001847903other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:00 PM ET
Size
5.9 KB
Accession
0000899243-22-013424
Insider Transaction Report
Form 4
Shahidi Javad
Chief Medical Officer
Transactions
- Award
Share Option (right to buy)
2022-04-01+330,000→ 330,000 totalExercise: $9.08Exp: 2032-04-01→ Ordinary Shares (330,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to such option shall vest and become exercisable on April 1, 2023 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001916875
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 6:00 PM ET
- Size
- 5.9 KB